Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2019, Article ID 9489826, 16 pages
https://doi.org/10.1155/2019/9489826
Review Article

Myocardial Ischemia and Diabetes Mellitus: Role of Oxidative Stress in the Connection between Cardiac Metabolism and Coronary Blood Flow

Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of Rome, 00161 Rome, Italy

Correspondence should be addressed to Francesco Fedele; ti.1amorinu@eledef.ocsecnarf

Received 10 December 2018; Revised 23 February 2019; Accepted 13 March 2019; Published 4 April 2019

Guest Editor: Julia M. dos Santos

Copyright © 2019 Paolo Severino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Fourth universal definition of myocardial infarction (2018),” European Heart Journal, vol. 40, no. 3, pp. 237–269, 2019. View at Publisher · View at Google Scholar
  2. E. Perugini, A. P. Maggioni, A. Boccanelli, and G. Di Pasquale, “Epidemiology of acute coronary syndromes in Italy,” Giornale Italiano di Cardiologia, vol. 11, no. 10, pp. 718–729, 2010. View at Google Scholar
  3. F. Sanchis-Gomar, C. Perez-Quilis, R. Leischik, and A. Lucia, “Epidemiology of coronary heart disease and acute coronary syndrome,” Annals of Translational Medicine, vol. 4, no. 13, p. 256, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell, “Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999,” Circulation, vol. 110, no. 10, pp. 1236–1244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. S. Reddy, “Cardiovascular disease in non-Western countries,” The New England Journal of Medicine, vol. 350, no. 24, pp. 2438–2440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Okrainec, D. K. Banerjee, and M. J. Eisenberg, “Coronary artery disease in the developing world,” American Heart Journal, vol. 148, no. 1, pp. 7–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Fedele, M. Mancone, W. M. Chilian et al., “Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease,” Basic Research in Cardiology, vol. 108, no. 6, p. 387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Severino, A. D’Amato, L. Netti et al., “Diabetes mellitus and ischemic heart disease: the role of ion channels,” International Journal of Molecular Sciences, vol. 19, no. 3, p. 802, 2018. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Fedele, P. Severino, N. Bruno et al., “Role of ion channels in coronary microcirculation: a review of the literature,” Future Cardiology, vol. 9, no. 6, pp. 897–905, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. G. Camici, G. D’Amati, and O. Rimoldi, “Coronary microvascular dysfunction: mechanisms and functional assessment,” Nature Reviews Cardiology, vol. 12, no. 1, pp. 48–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Crea, P. G. Camici, and C. N. Bairey Merz, “Coronary microvascular dysfunction: an update,” European Heart Journal, vol. 35, no. 17, pp. 1101–1111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Bairey Merz, R. O. Bonow, G. Sopko et al., “Women’s ischemic syndrome evaluation,” Circulation, vol. 109, no. 6, pp. 805–807, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Leuzzi and M. G. Modena, “Coronary artery disease: clinical presentation, diagnosis and prognosis in women,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 20, no. 6, pp. 426–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. A. DeVon, C. J. Ryan, A. L. Ochs, and M. Shapiro, “Symptoms across the continuum of acute coronary syndromes: differences between women and men,” American Journal of Critical Care, vol. 17, no. 1, pp. 14–24, 2008. View at Google Scholar
  15. C. N. Bairey Merz, L. J. Shaw, S. E. Reis et al., “Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study,” Journal of the American College of Cardiology, vol. 47, no. 3, pp. S21–S29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. W. Davies, “Clinical presentation and diagnosis of coronary artery disease: stable angina,” British Medical Bulletin, vol. 59, no. 1, pp. 17–27, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Čulić, D. Eterović, D. Mirić, and N. Silić, “Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors,” American Heart Journal, vol. 144, no. 6, pp. 1012–1017, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Stephen, B. G. Darney, and A. G. Rosenfeld, “Symptoms of acute coronary syndrome in women with diabetes: an integrative review of the literature,” Heart & Lung, vol. 37, no. 3, pp. 179–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. E. Reis, R. Holubkov, A. J. Conrad Smith et al., “Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study,” American Heart Journal, vol. 141, no. 5, pp. 735–741, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Hochman, C. H. McCabe, P. H. Stone et al., “Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI investigators. Thrombolysis in myocardial infarction,” Journal of the American College of Cardiology, vol. 30, no. 1, pp. 141–148, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. Shaw, C. N. Bairey Merz, C. J. Pepine et al., “Insights from the NHLBI- sponsored Women’s Ischemia Syndrome Evaluation (WISE) study,” Journal of the American College of Cardiology, vol. 47, no. 3, pp. S4–S20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. S. Rathore, J. Chen, Y. Wang, M. J. Radford, V. Vaccarino, and H. M. Krumholz, “Sex differences in cardiac catheterization,” Journal of the American Medical Association, vol. 286, no. 22, pp. 2849–2856, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Fedele, M. C. Gatto, A. D’Ambrosi, and M. Mancone, “TNM-like classification: a new proposed method for heart failure staging,” The Scientific World Journal, vol. 2013, Article ID 175925, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Fedele, P. Severino, S. Calcagno, and M. Mancone, “Heart failure: TNM-like classification,” Elsevier Journal of the American College of Cardiology, vol. 63, no. 19, pp. 1959-1960, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Koren-Morag, U. Goldbourt, and D. Tanne, “Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke,” American Heart Journal, vol. 155, no. 3, pp. 515–520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Moons, K. Van Deyk, and W. Budts, “The NYHA classification, employment, and physical activities are poor indicators of quality of life after congenital cardiac surgery,” The Annals of Thoracic Surgery, vol. 82, no. 3, pp. 1167-1168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chatterjee, K. Khunti, and M. J. Davies, “Type 2 diabetes,” The Lancet, vol. 389, no. 10085, pp. 2239–2251, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Nishikawa, D. Edelstein, X. L. du et al., “Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage,” Nature, vol. 404, no. 6779, pp. 787–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Yahagi, F. D. Kolodgie, C. Lutter et al., “Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 2, pp. 191–204, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Van Werkhoven, F. Cademartiri, S. Seitun et al., “Diabetes: prognostic value of CT coronary angiography—comparison with a nondiabetic population,” Radiology, vol. 256, no. 1, pp. 83–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. F. di Carli, J. Janisse, G. Grunberger, and J. Ager, “Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes,” Journal of the American College of Cardiology, vol. 41, no. 8, pp. 1387–1393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Yokoyama, S. Momomura, T. Ohtake et al., “Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus,” Journal of the American College of Cardiology, vol. 30, no. 6, pp. 1472–1477, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Kibel, K. Selthofer-Relatic, I. Drenjancevic et al., “Coronary microvascular dysfunction in diabetes mellitus,” The Journal of International Medical Research, vol. 45, no. 6, pp. 1901–1929, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Laakso, “Heart in diabetes: a microvascular disease,” Diabetes Care, vol. 34, Supplement 2, pp. S145–S149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. J. Flammer, T. Anderson, D. S. Celermajer et al., “The assessment of endothelial function,” Circulation, vol. 126, no. 6, pp. 753–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Virdis and S. Taddei, “Endothelial dysfunction in resistance arteries of hypertensive humans,” Journal of Cardiovascular Pharmacology, vol. 67, no. 6, pp. 451–457, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Lerman and A. M. Zeiher, “Endothelial function,” Circulation, vol. 111, no. 3, pp. 363–368, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Dessì, A. Noce, P. Bertucci et al., “Atherosclerosis, dyslipidemia, and inflammation: the significant role of polyunsaturated fatty acids,” ISRN Inflammation, vol. 2013, Article ID 191823, 13 pages, 2013. View at Publisher · View at Google Scholar
  39. A. Basoli, C. Cametti, F. G. Satriani, P. Mariani, and P. Severino, “Hemocompatibility of stent materials: alterations in electrical parameters of erythrocyte membranes,” Vascular Health and Risk Management, vol. 8, pp. 197–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. B. W. Wong, A. Meredith, D. Lin, and B. M. McManus, “The biological role of inflammation in atherosclerosis,” The Canadian Journal of Cardiology, vol. 28, no. 6, pp. 631–641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Balanescu, L. Calmac, D. Constantinescu, M. Marinescu, R. Onut, and M. Dorobantu, “Systemic inflammation and early atheroma formation: are they related?” Maedica, vol. 5, no. 4, pp. 292–301, 2010. View at Google Scholar
  42. A. Farzaneh-Far, M. J. Roman, M. D. Lockshin et al., “Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 54, no. 12, pp. 3918–3925, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Catapano, F. M. Maggi, and E. Tragni, “Low density lipoprotein oxidation, antioxidants, and atherosclerosis,” Current Opinion in Cardiology, vol. 15, no. 5, pp. 355–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Matzinger, “Tolerance, danger, and the extended family,” Annual Review of Immunology, vol. 12, no. 1, pp. 991–1045, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Martinon, K. Burns, and J. Tschopp, “The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Birben, U. M. Sahiner, C. Sackesen, S. Erzurum, and O. Kalayci, “Oxidative stress and antioxidant defense,” World Allergy Organization Journal, vol. 5, no. 1, pp. 9–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Bayr, “Reactive oxygen species,” Critical Care Medicine, vol. 33, no. 12, pp. S498–S501, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Humana Press, Clifton, NJ, USA, 1984.
  49. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Wang, K. Dhingra, W. N. Hittelman, J. G. Liehr, M. de Andrade, and D. Li, “Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues,” Cancer Epidemiology, Biomarkers & Prevention, vol. 5, no. 9, pp. 705–710, 1996. View at Google Scholar
  51. J. C. Jha, F. Ho, C. Dan, and K. Jandeleit-Dahm, “A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes,” Clinical Science, vol. 132, no. 16, pp. 1811–1836, 2018. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Maiese, “New insights for oxidative stress and diabetes mellitus,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 875961, 17 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Alwan, Global Status Report on Noncommunicable Diseases 2010, World Health Organization, 2011, http://www.cabdirect.org/cabdirect/abstract/20113168808.
  54. A. Dinesh Shah, C. Langenberg, E. Rapsomaniki et al., “Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1·9 million people,” The Lancet, vol. 385, article S86, 2015. View at Publisher · View at Google Scholar
  55. J. C. Jha, C. Banal, B. S. M. Chow, M. E. Cooper, and K. Jandeleit-Dahm, “Diabetes and kidney disease: role of oxidative stress,” Antioxidants & Redox Signaling, vol. 25, no. 12, pp. 657–684, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. J. C. Jha, C. Banal, J. Okabe et al., “NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy,” Diabetes, vol. 66, no. 10, pp. 2691–2703, 2017. View at Publisher · View at Google Scholar · View at Scopus
  57. J. C. Jha, S. P. Gray, D. Barit et al., “Genetic targeting or pharmacologic inhibition of NADPH oxidase Nox4 provides renoprotection in long-term diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1237–1254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. J. C. Jha, V. Thallas-Bonke, C. Banal et al., “Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy,” Diabetologia, vol. 59, no. 2, pp. 379–389, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Sardella, P. Stella, M. Chiarito et al., “Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: the INVESTIG8 registry,” Catheterization and Cardiovascular Interventions, vol. 91, no. 5, pp. 884–891, 2018. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Sardella, M. Mancone, R. E. Stio et al., “Prasugrel or ticagrelor in ST-segment–elevation myocardial infarction patients with diabetes mellitus,” Circulation, vol. 136, no. 6, pp. 602–604, 2017. View at Publisher · View at Google Scholar · View at Scopus
  61. I. Giardino, D. Edelstein, and M. Brownlee, “BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells,” The Journal of Clinical Investigation, vol. 97, no. 6, pp. 1422–1428, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. A. V. Sima, G. M. Botez, C. S. Stancu, A. Manea, M. Raicu, and M. Simionescu, “Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress,” Journal of Cellular and Molecular Medicine, vol. 14, no. 12, pp. 2790–2802, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Park, K. G. Raman, K. J. Lee et al., “Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts,” Nature Medicine, vol. 4, no. 9, pp. 1025–1031, 1998. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Ungurianu, D. Margină, D. Grădinaru et al., “Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease,” Molecular Medicine Reports, vol. 15, no. 1, pp. 256–262, 2017. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Sugimoto, T. Ishibashi, T. Sawamura et al., “LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells,” Cardiovascular Research, vol. 84, no. 1, pp. 127–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Galle, A. Heinloth, C. Wanner, and K. Heermeier, “Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress,” Kidney International, vol. 59, pp. S120–S123, 2001. View at Publisher · View at Google Scholar
  67. J. Chen, J. L. Mehta, N. Haider, X. Zhang, J. Narula, and D. Li, “Role of caspases in ox-LDL–induced apoptotic cascade in human coronary artery endothelial cells,” Circulation Research, vol. 94, no. 3, pp. 370–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Delafontaine and L. Ku, “Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells,” Cardiovascular Research, vol. 33, no. 1, pp. 216–222, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. T. J. Guzik, S. Mussa, D. Gastaldi et al., “Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase,” Circulation, vol. 105, no. 14, pp. 1656–1662, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. S. P. Gray, E. di Marco, J. Okabe et al., “NADPH oxidase 1 plays a key role in diabetes mellitus–accelerated atherosclerosis,” Circulation, vol. 127, no. 18, pp. 1888–1902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. S. P. Gray, E. di Marco, K. Kennedy et al., “Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 2, pp. 295–307, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Hu, X. Wu, A. R. Khandelwal et al., “Endothelial Nox4-based NADPH oxidase regulates atherosclerosis via soluble epoxide hydrolase,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1863, no. 6, pp. 1382–1391, 2017. View at Publisher · View at Google Scholar · View at Scopus
  73. Q. Zhang, P. Malik, D. Pandey et al., “Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 9, pp. 1627–1633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Münzel, C. Sinning, F. Post, A. Warnholtz, and E. Schulz, “Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction,” Annals of Medicine, vol. 40, no. 3, pp. 180–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Sifuentes-Franco, D. E. Padilla-Tejeda, S. Carrillo-Ibarra, and A. G. Miranda-Díaz, “Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy,” International Journal of Endocrinology, vol. 2018, Article ID 1875870, 13 pages, 2018. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Addabbo, M. Montagnani, and M. S. Goligorsky, “Mitochondria and reactive oxygen species,” Hypertension, vol. 53, no. 6, pp. 885–892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Azumi, N. Inoue, Y. Ohashi et al., “Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1838–1844, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Magenta, S. Greco, C. Gaetano, and F. Martelli, “Oxidative stress and microRNAs in vascular diseases,” International Journal of Molecular Sciences, vol. 14, no. 9, pp. 17319–17346, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Magenta, C. Cencioni, P. Fasanaro et al., “miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition,” Cell Death and Differentiation, vol. 18, no. 10, pp. 1628–1639, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Hui, L. Bakiri, A. Mairhorfer et al., “p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway,” Nature Genetics, vol. 39, no. 6, pp. 741–749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. I. Dolado, A. Swat, N. Ajenjo, G. De Vita, A. Cuadrado, and A. R. Nebreda, “p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis,” Cancer Cell, vol. 11, no. 2, pp. 191–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. H. Zhang, P. Gao, R. Fukuda et al., “HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity,” Cancer Cell, vol. 11, no. 5, pp. 407–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. M.-G. Perrelli, P. Pagliaro, and C. Penna, “Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species,” World Journal of Cardiology, vol. 3, no. 6, pp. 186–200, 2011. View at Publisher · View at Google Scholar
  84. C. Devlin, S. Greco, F. Martelli, and M. Ivan, “miR-210: more than a silent player in hypoxia,” IUBMB Life, vol. 63, no. 2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Y. Chan and J. Loscalzo, “MicroRNA-210: a unique and pleiotropic hypoxamir,” Cell Cycle, vol. 9, no. 6, pp. 1072–1083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Y. Chan, Y.-Y. Zhang, C. Hemann, C. E. Mahoney, J. L. Zweier, and J. Loscalzo, “MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2,” Cell Metabolism, vol. 10, no. 4, pp. 273–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Fasanaro, S. Greco, M. Lorenzi et al., “An integrated approach for experimental target identification of hypoxia-induced miR-210,” The Journal of Biological Chemistry, vol. 284, no. 50, pp. 35134–35143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Cicchillitti, V. di Stefano, E. Isaia et al., “Hypoxia-inducible factor 1-α induces miR-210 in normoxic differentiating myoblasts,” The Journal of Biological Chemistry, vol. 287, no. 53, pp. 44761–44771, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. R. K. Mutharasan, V. Nagpal, Y. Ichikawa, and H. Ardehali, “microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 301, no. 4, pp. H1519–H1530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. A. G. Goodwill, G. M. Dick, A. M. Kiel, and J. D. Tune, “Regulation of coronary blood flow,” Comprehensive Physiology, vol. 7, pp. 321–382, 2017. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Molinari, A. Battaglia, E. Grossini et al., “Effects of insulin on coronary blood flow in anesthetized pigs,” Journal of Vascular Research, vol. 39, no. 6, pp. 504–513, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. K. G. Lamping, H. Kanatsuka, C. L. Eastham, W. M. Chilian, and M. L. Marcus, “Nonuniform vasomotor responses of the coronary microcirculation to serotonin and vasopressin,” Circulation Research, vol. 65, no. 2, pp. 343–351, 1989. View at Publisher · View at Google Scholar · View at Scopus
  93. M. J. Kern, “Histaminergic modulation of coronary vascular resistance: are we missing a therapeutic adjunct for the treatment of myocardial ischemia?” Journal of the American College of Cardiology, vol. 17, no. 2, pp. 346-347, 1991. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Zhang, J. D. Knudson, S. Setty et al., “Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2154–H2162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. V. Ohanyan, L. Yin, R. Bardakjian et al., “Kv1.3 channels facilitate the connection between metabolism and blood flow in the heart,” Microcirculation, vol. 24, no. 4, article e12334, 2017. View at Publisher · View at Google Scholar · View at Scopus
  96. P. A. Rogers, W. M. Chilian, I. N. Bratz, R. M. Bryan Jr., and G. M. Dick, “H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 3, pp. H1404–H1411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Saitoh, C. Zhang, J. D. Tune et al., “Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2614–2621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. S. O. Sage, C. van Breemen, and M. B. Cannell, “Sodium-calcium exchange in cultured bovine pulmonary artery endothelial cells,” The Journal of Physiology, vol. 440, no. 1, pp. 569–580, 1991. View at Publisher · View at Google Scholar · View at Scopus
  99. G. M. Dick, I. N. Bratz, L. Borbouse et al., “Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 294, no. 5, pp. H2371–H2381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. V. Ohanyan, L. Yin, R. Bardakjian et al., “Requisite role of Kv1.5 channels in coronary metabolic dilation,” Circulation Research, vol. 117, no. 7, pp. 612–621, 2015. View at Publisher · View at Google Scholar · View at Scopus
  101. R. S. Barlow and R. E. White, “Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCachannel activity,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 275, no. 4, pp. H1283–H1289, 1998. View at Publisher · View at Google Scholar
  102. R. S. Barlow, A. M. El-Mowafy, and R. E. White, “H2O2 opens BKCa channels via the PLA2-arachidonic acid signaling cascade in coronary artery smooth muscle,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 279, no. 2, pp. H475–H483, 2000. View at Publisher · View at Google Scholar
  103. G. M. Dick and J. D. Tune, “Role of potassium channels in coronary vasodilation,” Experimental Biology and Medicine, vol. 235, no. 1, pp. 10–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Thengchaisri and L. Kuo, “Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 285, no. 6, pp. H2255–H2263, 2003. View at Publisher · View at Google Scholar
  105. S. L. Hu, H. S. Kim, and A. Y. Jeng, “Dual action of endothelin-1 on the Ca2+-activated K+ channel in smooth muscle cells of porcine coronary artery,” European Journal of Pharmacology, vol. 194, no. 1, pp. 31–36, 1991. View at Publisher · View at Google Scholar · View at Scopus
  106. F. S. Scornik and L. Toro, “U46619, a thromboxane A2 agonist, inhibits KCa channel activity from pig coronary artery,” American Journal of Physiology-Cell Physiology, vol. 262, no. 3, pp. C708–C713, 1992. View at Publisher · View at Google Scholar
  107. L. Toro, M. Amador, and E. Stefani, “ANG II inhibits calcium-activated potassium channels from coronary smooth muscle in lipid bilayers,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 258, no. 3, pp. H912–H915, 1990. View at Publisher · View at Google Scholar
  108. K. Minami, Y. Hirata, A. Tokumura, Y. Nakaya, and K. Fukuzawa, “Protein kinase C-independent inhibition of the Ca2+-activated K+ channel by angiotensin IIand endothelin-1,” Biochemical Pharmacology, vol. 49, no. 8, pp. 1051–1056, 1995. View at Publisher · View at Google Scholar · View at Scopus
  109. P. K. Randhawa and A. S. Jaggi, “TRPV 1 channels in cardiovascular system: a double edged sword?” International Journal of Cardiology, vol. 228, pp. 103–113, 2017. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Qin, S. Liu, and R. Wang, “Protective effect of capsaicin on against myocardial ischemia-reperfusion injury of rat in vivo,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 39, no. 4, pp. 550–554, 2008. View at Google Scholar
  111. T. Yada, H. Shimokawa, O. Hiramatsu et al., “Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo,” Circulation, vol. 107, no. 7, pp. 1040–1045, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. T. Matoba, H. Shimokawa, K. Morikawa et al., “Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 7, pp. 1224–1230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. N. B. Standen and J. M. Quayle, “K+ channel modulation in arterial smooth muscle,” Acta Physiologica Scandinavica, vol. 164, no. 4, pp. 549–557, 1998. View at Publisher · View at Google Scholar · View at Scopus
  114. L. Conforti, I. Bodi, J. W. Nisbet, and D. E. Millhorn, “O2-sensitive K+ channels: role of the Kv1.2 α-subunit in mediating the hypoxic response,” The Journal of Physiology, vol. 524, no. 3, pp. 783–793, 2000. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Fedele, M. Mancone, F. Adamo, and P. Severino, “Heart failure with preserved, mid-range, and reduced ejection fraction: the misleading definition of the new guidelines,” Cardiology in Review, vol. 25, no. 1, pp. 4-5, 2017. View at Publisher · View at Google Scholar · View at Scopus
  116. G. Jia, J. Habibi, A. R. Aroor et al., “Enhanced endothelium epithelial sodium channel signaling prompts left ventricular diastolic dysfunction in obese female mice,” Metabolism, vol. 78, pp. 69–79, 2018. View at Publisher · View at Google Scholar · View at Scopus
  117. B. Bostick, J. Habibi, L. Ma et al., “Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity,” Metabolism, vol. 63, no. 8, pp. 1000–1011, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. B. Bostick, A. R. Aroor, J. Habibi et al., “Daily exercise prevents diastolic dysfunction and oxidative stress in a female mouse model of western diet induced obesity by maintaining cardiac heme oxygenase-1 levels,” Metabolism, vol. 66, pp. 14–22, 2017. View at Publisher · View at Google Scholar · View at Scopus
  119. C. H. Mandavia, L. Pulakat, V. DeMarco, and J. R. Sowers, “Over-nutrition and metabolic cardiomyopathy,” Metabolism, vol. 61, no. 9, pp. 1205–1210, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Tomaschitz, E. Ritz, B. Pieske et al., “Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease,” Metabolism, vol. 63, no. 1, pp. 20–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. G. Jia, J. Habibi, V. G. DeMarco et al., “Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females,” Hypertension, vol. 66, no. 6, pp. 1159–1167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Kenchaiah, J. C. Evans, D. Levy et al., “Obesity and the risk of heart failure,” The New England Journal of Medicine, vol. 347, no. 5, pp. 305–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Fels, P. Jeggle, K. Kusche-Vihrog, and H. Oberleithner, “Cortical actin nanodynamics determines nitric oxide release in vascular endothelium,” PLoS One, vol. 7, no. 7, article e41520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. Y. Zeng, M. Waters, A. Andrews et al., “Fluid shear stress induces the clustering of heparan sulfate via mobility of glypican-1 in lipid rafts,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 305, no. 6, pp. H811–H820, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. M. M. Dwenger, V. Ohanyan, M. F. Navedo, and M. A. Nystoriak, “Coronary microvascular Kv1 channels as regulatory sensors of intracellular pyridine nucleotide redox potential,” Microcirculation, vol. 25, no. 1, article e12426, 2018. View at Publisher · View at Google Scholar · View at Scopus
  126. M. W. Weiner and H. A. Lardy, “Reduction of pyridine nucleotides induced by adenosine diphosphate in kidney mitochondria. The influence of sodium, magnesium, and inhibitors of oxidative phosphorylation,” The Journal of Biological Chemistry, vol. 248, no. 22, pp. 7682–7687, 1973. View at Google Scholar
  127. F. Dayanikli, D. Grambow, O. Muzik, L. Mosca, M. Rubenfire, and M. Schwaiger, “Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography,” Circulation, vol. 90, no. 2, pp. 808–817, 1994. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Kelm, “Nitric oxide metabolism and breakdown,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1411, no. 2-3, pp. 273–289, 1999. View at Publisher · View at Google Scholar · View at Scopus
  129. H. Li, D. D. Gutterman, N. J. Rusch, A. Bubolz, and Y. Liu, “Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose,” Diabetes, vol. 53, no. 9, pp. 2436–2442, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. D. J. DelloStritto, P. Sinharoy, P. J. Connell et al., “4-Hydroxynonenal dependent alteration of TRPV1-mediated coronary microvascular signaling,” Free Radical Biology & Medicine, vol. 101, pp. 10–19, 2016. View at Publisher · View at Google Scholar · View at Scopus
  131. H. Chuang and S. Lin, “Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 20097–20102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  132. D. A. Andersson, C. Gentry, S. Moss, and S. Bevan, “Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress,” The Journal of Neuroscience, vol. 28, no. 10, pp. 2485–2494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. G. Guarini, V. A. Ohanyan, J. G. Kmetz et al., “Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 303, no. 2, pp. H216–H223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. S. J. Chapple, X. Cheng, and G. E. Mann, “Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease,” Redox Biology, vol. 1, no. 1, pp. 319–331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. V. R. Mali and S. S. Palaniyandi, “Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease,” Free Radical Research, vol. 48, no. 3, pp. 251–263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. H. N. Rubaiy, “The therapeutic agents that target ATP-sensitive potassium channels,” Acta Pharmaceutica, vol. 66, no. 1, pp. 23–34, 2016. View at Publisher · View at Google Scholar
  137. M. Matsuo, K. Tanabe, N. Kioka, T. Amachi, and K. Ueda, “Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B,” The Journal of Biological Chemistry, vol. 275, no. 37, article 28757- 28763, pp. 28757–28763, 2000. View at Publisher · View at Google Scholar · View at Scopus
  138. S. Isomoto and Y. Kurachi, “Molecular and biophysical aspects of potassium channels,” Nihon Rinsho, vol. 54, no. 3, pp. 660–666, 1996. View at Google Scholar
  139. M. Schwanstecher, C. Sieverding, H. Dörschner et al., “Potassium channel openers require ATP to bind to and act through sulfonylurea receptors,” The EMBO Journal, vol. 17, no. 19, pp. 5529–5535, 1998. View at Publisher · View at Google Scholar · View at Scopus
  140. F. Zhang, Y. Xuan, J. Cui, X. Liu, Z. Shao, and B. Yu, “Nicorandil modulated macrophages activation and polarization via NF-κb signaling pathway,” Molecular Immunology, vol. 88, pp. 69–78, 2017. View at Publisher · View at Google Scholar · View at Scopus
  141. S. H. Rezkalla, R. V. Stankowski, J. Hanna, and R. A. Kloner, “Management of no-reflow phenomenon in the catheterization laboratory,” JACC Cardiovascular Interventions, vol. 10, no. 3, pp. 215–223, 2017. View at Publisher · View at Google Scholar · View at Scopus
  142. C. Kupatt, H. Habazettl, A. Goedecke et al., “Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts,” Circulation Research, vol. 84, no. 4, pp. 392–400, 1999. View at Publisher · View at Google Scholar · View at Scopus
  143. IONA Study Group, “Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial,” The Lancet, vol. 359, no. 9314, pp. 1269–1275, 2002. View at Publisher · View at Google Scholar · View at Scopus
  144. M. S. Nieminen, M. Buerke, J. Parissis et al., “Pharmaco-economics of levosimendan in cardiology: a European perspective,” International Journal of Cardiology, vol. 199, pp. 337–341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Bunte, F. Behmenburg, A. Bongartz et al., “Preconditioning by levosimendan is mediated by activation of mitochondrial Ca2+-sensitive potassium (mBKCa) channels,” Cardiovascular Drugs and Therapy, vol. 32, no. 5, pp. 427–434, 2018. View at Publisher · View at Google Scholar · View at Scopus
  146. J. G. Papp, P. Pollesello, A. F. Varró, and Á. S. Végh, “Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 11, no. 2, pp. 129–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. W. Xu, Y. Liu, S. Wang et al., “Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane,” Science, vol. 298, no. 5595, pp. 1029–1033, 2002. View at Publisher · View at Google Scholar · View at Scopus
  148. C. C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan, “Potassium channels: molecular defects, diseases, and therapeutic opportunities,” Pharmacological Reviews, vol. 52, no. 4, pp. 557–594, 2000. View at Google Scholar
  149. I. Grgic, B. P. Kaistha, J. Hoyer, and R. Köhler, “Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses - relevance to cardiovascular pathologies and drug discovery,” British Journal of Pharmacology, vol. 157, no. 4, pp. 509–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  150. X.-C. Wang, W.-T. Sun, J. Fu et al., “Impairment of coronary endothelial function by hypoxia-reoxygenation involves TRPC3 inhibition-mediated KCa channel dysfunction: implication in ischemia-reperfusion injury,” Scientific Reports, vol. 7, no. 1, p. 5895, 2017. View at Publisher · View at Google Scholar · View at Scopus
  151. C. Yin, Y. Chen, H. Wu, D. Xu, and W. Tan, “Attenuation of ischemia/reperfusion- induced inhibition of the rapid component of delayed rectifier potassium current by Isosteviol through scavenging reactive oxygen species,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1859, no. 12, pp. 2447–2453, 2017. View at Publisher · View at Google Scholar · View at Scopus
  152. L. Lai, R. Wang, W. Jiang et al., “Effects of docosahexaenoic acid on large-conductance Ca2+-activated K+ channels and voltage-dependent K+ channels in rat coronary artery smooth muscle cells,” Acta Pharmacologica Sinica, vol. 30, no. 3, pp. 314–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  153. X. Li, S. Hong, P.-L. Li, and Y. Zhang, “Docosahexanoic acid-induced coronary arterial dilation: actions of 17S-hydroxy docosahexanoic acid on K+ channel activity,” The Journal of Pharmacology and Experimental Therapeutics, vol. 336, no. 3, pp. 891–899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  154. R. Wang, Q. Chai, T. Lu, and H.-C. Lee, “Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity,” Cardiovascular Research, vol. 90, no. 2, pp. 344–352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. X. Tang, L. L. Qian, R. X. Wang et al., “Regulation of coronary arterial large conductance Ca2+-activated K+ channel protein expression and function by n-3 polyunsaturated fatty acids in diabetic rats,” Journal of Vascular Research, vol. 54, no. 6, pp. 329–343, 2017. View at Publisher · View at Google Scholar · View at Scopus
  156. G. Zhou, Y. Wang, P. He, and D. Li, “Probucol inhibited Nox2 expression and attenuated podocyte injury in type 2 diabetic nephropathy of db/db mice,” Biological & Pharmaceutical Bulletin, vol. 36, no. 12, pp. 1883–1890, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. K. Susztak, A. C. Raff, M. Schiffer, and E. P. Böttinger, “Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy,” Diabetes, vol. 55, no. 1, pp. 225–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  158. Y. Ding, Z.-J. Chen, S. Liu, D. Che, M. Vetter, and C.-H. Chang, “Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone,” The Journal of Pharmacy and Pharmacology, vol. 57, no. 1, pp. 111–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  159. E. Anvari, P. Wikström, E. Walum, and N. Welsh, “The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice,” Free Radical Research, vol. 49, no. 11, pp. 1308–1318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  160. S. P. Gray, J. C. Jha, K. Kennedy et al., “Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease,” Diabetologia, vol. 60, no. 5, pp. 927–937, 2017. View at Publisher · View at Google Scholar · View at Scopus
  161. S. K. Nelson, S. K. Bose, G. K. Grunwald, P. Myhill, and J. M. McCord, “The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy,” Free Radical Biology & Medicine, vol. 40, no. 2, pp. 341–347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  162. E. L. Donovan, J. M. McCord, D. J. Reuland, B. F. Miller, and K. L. Hamilton, “Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 132931, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  163. U. Milman, S. Blum, C. Shapira et al., “Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 341–347, 2008. View at Publisher · View at Google Scholar · View at Scopus